title: Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.
authors.affiliation: Departments of Physiology and Functional Genomics, University of Florida, Gainesville, Fla 32610, USA.
authors.forename: Anderson J
authors.initials: AJ
authors.lastname: Ferreira
authors.forename: Robson A S
authors.initials: RA
authors.lastname: Santos
authors.forename: Chastity N
authors.initials: CN
authors.lastname: Bradford
authors.forename: Adam P
authors.initials: AP
authors.lastname: Mecca
authors.forename: Colin
authors.initials: C
authors.lastname: Sumners
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Katovich
authors.forename: Mohan K
authors.initials: MK
authors.lastname: Raizada
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D011379:Prognosis; D012084:Renin-Angiotensin System / Q000187:drug effects* / Q000502:physiology; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors